• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[人乳头瘤病毒感染时子宫颈上皮细胞增殖活性的测定]

[Determination of the proliferative activity of the cervix uteri epithelium in papillomavirus infection].

作者信息

Manukhin I B, Frank G A, Minkina G N, Simonova T V, Kulagina L A

出版信息

Vestn Ross Akad Med Nauk. 1997(2):20-4.

PMID:9376722
Abstract

The results of examinations of 35 patients aged 17 to 42 years who had abnormalities in the cervix uteri were analyzed. Colposcopy detected an atypical epithelium in 100% of cases. To verify the diagnosis, biopsy specimens from the cervix uteri were morphologically studied prior to and following treatment. Before treatment, there was a slight proliferative activity of the epithelium in 45% of cases and its high proliferative activity in 15% in uncomplicated papilloma viral infection (PVI). A follow-up of complicated PVI indicated increases in the expression of a proliferative nuclear antigen (PVA) with higher dysplasia: a moderate response in 75% of D3 + PVI cases and a higher response in 60% of preinvasive cancers. Analysis of PCNA-immunological reactivity of biopsy specimens taken after treatment estimates the efficiency of the chosen complex of treatments: there was a negative result of immunohistochemical responses.

摘要

对35名年龄在17至42岁之间子宫颈有异常的患者的检查结果进行了分析。阴道镜检查在100%的病例中检测到非典型上皮。为了核实诊断,在治疗前后对子宫颈活检标本进行了形态学研究。在未合并乳头瘤病毒感染(PVI)的情况下,治疗前45%的病例上皮有轻微增殖活性,15%有高增殖活性。对合并PVI的随访表明,随着发育异常程度加重,增殖细胞核抗原(PVA)表达增加:在75%的D3 + PVI病例中有中度反应,在60%的浸润前癌中有高度反应。对治疗后活检标本的PCNA免疫反应性分析评估了所选综合治疗的效果:免疫组化反应结果为阴性。

相似文献

1
[Determination of the proliferative activity of the cervix uteri epithelium in papillomavirus infection].[人乳头瘤病毒感染时子宫颈上皮细胞增殖活性的测定]
Vestn Ross Akad Med Nauk. 1997(2):20-4.
2
[Immunotherapy with cutaneous dinitrochlorobenzene in papillomavirus infection of the cervix uteri].[子宫颈乳头瘤病毒感染的皮肤二硝基氯苯免疫疗法]
Rev Chil Obstet Ginecol. 1991;56(6):460-3.
3
[The colposcopic characteristics of the pathological processes in the cervix uteri associated with papillomavirus infection].
Lik Sprava. 1999 Jan-Feb(1):67-70.
4
Human cervical papillomavirus infection: a clinical perspective.
IARC Sci Publ. 1989(94):41-65.
5
HPV test: antidote to ASCUS headache?
CAP Today. 1996 Sep;10(9):1, 52-4, 56-8.
6
Multivariate discriminant analysis of normal, intraepithelial neoplasia and human papillomavirus infection of the uterine cervix samples.
Histol Histopathol. 1994 Jan;9(1):135-40.
7
[Clinical and morphologic aspects of cervical papillomavirus infection].
Vopr Onkol. 2002;48(1):43-6.
8
[Proliferating cell nuclear antigen in precancerous cervical disease].[增殖细胞核抗原在子宫颈癌前病变中的表达]
Arkh Patol. 1997 Jan-Feb;59(1):30-3.
9
[Colposcopic, cyto- and histologic signs of papilloma virus infection in precancerous and early stages of cervix cancer].[宫颈癌癌前病变及早期阶段乳头瘤病毒感染的阴道镜、细胞及组织学征象]
Zentralbl Gynakol. 1990;112(1):23-31.
10
[The cytological characteristics of the cells of the multilayer squamous epithelium of the cervix uteri in relation to the association of the pathological processes with the human papilloma virus].
Tsitol Genet. 1997 Nov-Dec;31(6):3-11.